HAP Trading’s AstraZeneca AZN Stock Holding History

HAP Trading’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,900	Closed	-$304K	–	741
2025 Q1	$304K	Buy	+25,900	New	+$3.75M	0.03%	247
2023 Q2	–	Sell	-61,800	Closed	-$220K	–	1101
2023 Q1	$220K	Buy	61,800 +54,800	+783%	+$7.37M	0.03%	300
2022 Q4	$47K	Sell	7,000 -1,500	-18%	-$188K	﹤0.01%	754
2022 Q3	$9K	Buy	8,500 +3,350	+65%	+$425K	﹤0.01%	1342
2022 Q2	$53K	Sell	5,150 -48,000	-90%	-$6.3M	﹤0.01%	1041
2022 Q1	$370K	Buy	53,150 +33,550	+171%	+$4.02M	0.02%	638
2021 Q4	$78K	Sell	19,600 -6,150	-24%	-$724K	﹤0.01%	1308
2021 Q3	$152K	Buy	25,750 +4,200	+19%	+$489K	﹤0.01%	1129
2021 Q2	$215K	Sell	21,550 -11,750	-35%	-$1.29M	0.01%	984
2021 Q1	$117K	Sell	33,300 -31,300	-48%	-$3.15M	0.01%	899
2020 Q4	$132K	Buy	64,600 +8,500	+15%	+$900K	﹤0.01%	1080
2020 Q3	$127K	Buy	56,100 +26,250	+88%	+$2.92M	0.01%	752
2020 Q2	$178K	Buy	29,850 +23,100	+342%	+$2.39M	0.01%	706
2020 Q1	$28K	Sell	6,750 -8,400	-55%	-$791K	﹤0.01%	873
2019 Q4	$250K	Buy	15,150 +2,100	+16%	+$198K	0.01%	420
2019 Q3	$149K	Buy	13,050 +6,000	+85%	+$520K	0.01%	556
2019 Q2	$16K	Buy	+7,050	New	+$553K	﹤0.01%	913
2018 Q3	–	Sell	-5,600	Closed	-$20K	–	995
2018 Q2	$20K	Sell	5,600 -2,550	-31%	-$183K	﹤0.01%	805
2018 Q1	$19K	Sell	8,150 -43,900	-84%	-$3.04M	﹤0.01%	773
2017 Q4	$51K	Sell	52,050 -1,000	-2%	-$67.4K	﹤0.01%	661
2017 Q3	$116K	Sell	53,050 -334,550	-86%	-$21.1M	0.01%	561
2017 Q2	$1.61M	Sell	387,600 -29,050	-7%	-$1.9M	0.09%	195
2017 Q1	$599K	Buy	+416,650	New	+$24.3M	0.04%	311
2015 Q1	–	Sell	-60,400	Closed	-$14K	–	929
2014 Q4	$14K	Hold	60,400	–	–	﹤0.01%	876
2014 Q3	$64K	Buy	60,400 +13,100	+28%	+$959K	﹤0.01%	724
2014 Q2	$48K	Buy	+47,300	New	+$3.42M	﹤0.01%	728

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HAP Trading's AZN Position: Q3 2025 in Review

HAP Trading reduced its AstraZeneca (AZN) stake by 57% in Q3 2025, selling an estimated $1.93M and leaving 9,483 shares worth $1.45M. The position accounts for 0.1% of the portfolio, ranked #131.

HAP Trading first reported a position in AZN in Q2 2013 and has held it in 27 quarters since. The position peaked at $18.8M in Q1 2017. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

HAP Trading held 9,483 shares of AstraZeneca worth $1.45M as of Q3 2025.
HAP Trading sold 12,784 AstraZeneca shares in Q3 2025, an estimated $1.93M.
AstraZeneca made up 0.1% of HAP Trading's portfolio in Q3 2025, its #131 holding.
HAP Trading first reported a position in AstraZeneca in Q2 2013 and has held it in 27 quarters since.
HAP Trading's AstraZeneca position peaked at $18.8M in Q1 2017.
1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.